Sigma-Aldrich to distribute Olink Bioscience products worldwide

Sigma-Aldrich has confirmed it has signed an agreement to distribute Olink Bioscience's Duolink In Situ products all over the world.

They present a new disruptive method for imaging and measuring protein-protein interactions in unmodified cells and Sigma-Aldrich will be building awareness of the range.

Josef Zihlmann, vice-president at Sigma Life Science, stated that the partnership is set to enable the scientific community to access and accelerate the adoption of the powerful Duolink technology.

"The ability to visualise these protein-protein interactions in unmodified cells under endogenous expression and at very low levels is a fundamental advance that allows greater insight into basic biology, pathways, spatial phenomena and potential therapeutic targets," said Mr Zihlmann.

It was noted by the company that over 350 publications in the last six years have relied upon the Duolink method.

This comes shortly after Sigma-Aldrich revealed its financial results for the year 2012, which saw its reported sales rise by seven per cent over the period.